Early testing at IRCAD demonstrates promising effects of automated instrument switching.

A pre-clinical usability study conducted at IRCAD suggests that Symphera’s automated instrument-switching system could

Dr. Parker brings extensive expertise in minimally invasive and robotic surgery.

Symphera welcomes Dr. Brett Parker, Assistant Professor of Surgery at Johns Hopkins School of

The European Union grant supports Symphera’s work toward bringing its device to market.

Symphera has been awarded a highly competitive EIC Accelerator grant to accelerate

The FDA’s STeP program recognizes technologies with strong potential to improve patient safety.

Symphera has been accepted into the FDA’s Safer Technologies Program (STeP), a

The program provides Symphera with strategic mentorship and direct entry points into the US market.

Symphera has been selected for the prestigious German Accelerator US